Monopar

Monopar Therapeutics is an emerging biopharmaceutical company dedicated to developing innovative drugs and drug combinations to improve clinical outcomes for cancer patients. The company is building a drug development pipeline by licensing and acquiring oncology therapeutics in late-stage preclinical and clinical development. It leverages its scientific and clinical expertise to help mitigate risks and accelerate the clinical development of its drug candidates.